In the Journals

Researchers propose diagnostic criteria for drug-induced intracranial hypertension

December 4, 2019
Common medications to treat acne and other inflammatory dermatoses strongly associated with drug-induced intracranial hypertension include vitamin A…

In the Journals

Risk for immune-mediated inflammatory diseases 5-times higher in psoriasis

December 3, 2019
Among a large cohort of patients with psoriasis, researchers found around 20% had an immune-mediated inflammatory disease develop before psoriasis…

Meeting News

Experts create algorithm for management of cutaneous manifestations in lupus

November 20, 2019
Researchers compiled a treatment algorithm for cutaneous manifestations of lupus erythematosus based on data from 104 studies, according to a study…

Meeting News

Any smoking exposure in patients with lupus affects cutaneous manifestations

November 15, 2019
Researchers suggested there is a dose relationship between smoking exposure and cutaneous manifestations in systemic lupus erythematosus, which…

Meeting News

Steering committee develops evidence-based consensus on cSCC staging, workup, treatment

October 28, 2019
CHICAGO — In patients with advanced cutaneous squamous cell carcinoma, a multidisciplinary discussion on treatment options should include…

Meeting News

Adjunctive fractional CO2 laser treatment improves symptoms of vulvar lichen sclerosus

October 24, 2019
CHICAGO — Fractional CO2 laser treatment was associated with improved signs and symptoms of vulvar lichen sclerosus, according to data from a…

Meeting News

Nano-pulse stimulation reduces nongenital wart size

October 24, 2019
CHICAGO — Nano-pulse stimulation was associated with a reduction in cutaneous, nongenital wart size, according to data from a multicenter study…

Meeting News

Bermekimab improves all disease measures of atopic dermatitis in phase 2 study

October 16, 2019
Bermekimab, which neutralizes interleukin-1 alpha, improved all disease measures of atopic dermatitis, including a large reduction in pruritus…

Meeting News

Oral JAK inhibitor improves alopecia areata severity

October 15, 2019
Patients with moderate to severe alopecia areata who were assigned to CTP-543, an oral Janus kinase inhibitor from Concert Pharmaceuticals, achieved…

At-home therapy plus in-office treatment maximizes hair growth investment

October 15, 2019
by Deanne Mraz Robinson, MD Androgenetic alopecia, or AGA, is the most common form of hair loss, affecting up to 80% of men and 50% of women. This…

Meeting News

4-year data demonstrate safety, efficacy of Ilumya in plaque psoriasis

October 11, 2019
The safety and efficacy of Ilumya were maintained after 4 years of treatment among patients with plaque psoriasis enrolled in the open-label…

In the Journals

Greater QoL, pain improvement in psoriasis with phototherapy vs. adalimumab

October 8, 2019
Adalimumab and phototherapy for psoriasis are both associated with statistically significant improvements in patient-reported outcomes after 12…

Topical solution from Aclaris clears warts by day 29 in phase 3 study

September 17, 2019
Aclaris Therapeutics announced positive results from a phase 3 clinical trial of A-101 45% topical solution, an investigational new drug for the…

Five updates for Alopecia Areata Awareness Month

September 5, 2019
Alopecia areata affects up to 6.8 million people in the U.S. and carries a 2.1% lifetime risk, according to the National Alopecia Areata Foundation…

In the Journals

Methotrexate not a superior therapy for chronic spontaneous urticaria

August 23, 2019
Methotrexate may be used as a third-line therapy for treating chronic spontaneous urticaria, but it was not superior to placebo added to…

Four popular headlines to highlight Psoriasis Action Month

August 21, 2019
Earlier this month, Healio Dermatology posted a compilation of eight popular reads to kickoff Psoriasis Action Month in psoriasis research, advocacy…

In the JournalsPerspective

Joint guidelines explore best practices in NB-UVB therapy for psoriasis

August 6, 2019
Based on the available literature, the American Academy of Dermatology and the National Psoriasis Foundation published joint guidelines on…

Bausch Health, Walgreens program supports lower pricing on many dermatology products

August 6, 2019
Bausch Health announced the expansion of its dermatology prescription program with Walgreens stores in the U.S. “Under the expanded agreement…

In the Journals

Biologic therapy for psoriasis reduces coronary inflammation

August 1, 2019
Biologic therapy for moderate to severe psoriasis reduced in coronary inflammation, as assessed by perivascular fat attenuation index via coronary…

In the Journals

Some systemic psoriasis treatments may be associated with UTI risk

July 29, 2019
The use of cyclosporine, infliximab and anti-IL17 in the treatment of psoriasis is associated with a higher risk for symptomatic urinary tract…

Healio Jobs